Recent Financing
Recent Raise
Koronis Pharmaceuticals develops antiviral nucleoside-analogue small molecules, including KP-1212/KP-1461, that incorporate into viral genomes to accelerate mutation rates and target HIV replication.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors